Cell and Advanced Therapies Supply Chain Management Market, 2020-2030

By | October 1, 2021

To order this 510+ page report, please visit this – https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html Key Inclusions A detailed assessment of the current market landscape, featuring a comprehensive list of over 160 technological platforms that are being used to manage the cell and advanced therapies supply chain, along with information on the different types of software systems (COP, EMS, IMS, LIMS, LMS,… Read More »

The cell therapy manufacturing market Roots Analysis

By | October 1, 2021

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030”.” The report features an extensive study of… Read More »

China Pharmaceutical Contract Manufacturing Services Market, 2020-2030

By | October 1, 2021

Report link – https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html Key Inclusions  A review of the current market landscape of companies offering pharmaceutical contract manufacturing services in China, along with information on year of establishment, company size, location of headquarters, type of product (active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs)), type of FDFs, type of packaging and number of manufacturing… Read More »

The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis

By | September 24, 2021

Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages Roots Analysis is pleased to announce the publication of its recent study, titled, “Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage… Read More »

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment, claims Roots Analysis

By | September 24, 2021

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient… Read More »

The biopharmaceutical CROs market is projected to be worth USD 67 billion by 2030, claims Roots Analysis

By | September 17, 2021

Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order to remain competitive, flexible, and profitable in the industry Roots Analysis has announced the addition of “Biopharmaceutical CROs Market, 2021-2030,” report to its list of offerings. Given their numerous advantages, which include high… Read More »